OS Therapies names Kerry Clem chief commercial officer

OS Therapies has appointed Kerry Clem as chief commercial officer to oversee the U.S., U.K., and European launch planning for Herlystic. Frank Knuettel II has been appointed chief financial officer as the company prepares for commercialization.